\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\ exam\\ was\\ significant\\ for\\ a\\ fib\\ with\\ distant\\ heart\\ sounds\\.\ \(0\)\
\-\ treatment\\ was\\ achieved\\ by\\ surgical\\ evacuation\\ of\\ pericardial\\ effusion\\.\ \(0\)\
\-\ pa\\ and\\ lateral\\ chest\\ x\\-ray\\:\\ \\ an\\ enlarged\\ cardiac\\ sillouette\\ is\\ demonstrated\\ with\\ a\\ water\\-bottle\\ shape\\.\\ \\ on\\ the\\ lateral\\ view\\,\\ a\\ density\\ following\\ the\\ border\\ of\\ the\\ heart\\ is\\ seen\\ anteriorly\\ next\\ to\\ a\\ lucent\\ margin\\.\\ \ \(0\)\
\-\ chest\\ ct\\:\\ \\ a\\ large\\ pericardial\\ effusion\\ is\\ demonstrated\\ with\\ anterior\\ parietal\\ pericardial\\ thickness\\ maximally\\ 2\\ mm\\ without\\ pericardial\\ enhancement\\.\ \(0\)\
\-\ pericardial\\ effusion\\,\\ possibly\\ dressler\\'s\\ syndrome\\.\ \(0\)\
\-\ the\\ differential\\ for\\ findings\\ seen\\ on\\ cxr\\ include\\ pericardial\\ effusion\\,\\ dilated\\ cardiomyopathy\\,\\ chf\\,\\ and\\ aortic\\ dissection\\.\ \(0\)\
\-\ the\\ differential\\ causes\\ for\\ pericardial\\ effusion\\ include\\ infectious\\,\\ autoimmune\\,\\ neoplastic\\,\\ drug\\ induced\\,\\ metabolic\\,\\ sarcoidosis\\,\\ pancreatitis\\,\\ and\\ trauma\ \(0\)\
\-\ 76\\ yo\\ male\\ presented\\ with\\ le\\ swelling\\ and\\ pain\\.\\ \\ pt\\ had\\ mi\\ and\\ ptca\\ 3\\ months\\ prior\\ and\\ had\\ been\\ sob\\ since\\ that\\ time\\ for\\ which\\ he\\ was\\ treated\\ with\\ increasing\\ doses\\ of\\ lasix\\ for\\ presumed\\ chf\\ without\\ relief\\.\\ \\ pt\\ was\\ also\\ on\\ coumadin\\ for\\ chronic\\ atrial\\ fibrillation\\ with\\ inr\\ in\\ therapeutic\\ range\\.\ \(0\)\
\-\ a\\ pericardial\\ effusion\\ is\\ an\\ increase\\ in\\ fluid\\ within\\ the\\ space\\ between\\ the\\ visceral\\ and\\ parietal\\ pericardium\\.\\ \\ it\\ is\\ the\\ most\\ common\\ abnormality\\ of\\ the\\ pericardium\\.\\ \\ normally\\,\\ 20cc\\ of\\ fluid\\ is\\ within\\ this\\ space\\,\\ but\\ 200cc\\ is\\ needed\\ for\\ identification\\ on\\ plain\\ film\\ which\\ is\\ demonstated\\ by\\ thickening\\ of\\ the\\ pericardial\\ stripe\\ greater\\ than\\ 2\\-3mm\\ or\\ differential\\ density\\ sign\\.\\ the\\ differential\\ density\\ sign\\ is\\ the\\ lucent\\ margin\\ along\\ the\\ lateral\\ or\\ posterior\\ heart\\ border\\ seen\\ in\\ 63\\%\\ of\\ pericardial\\ effusions\\.\\ \\ although\\ this\\ sign\\ is\\ more\\ sensitive\\ than\\ the\\ thickened\\ pericardial\\ stripe\\ seen\\ in\\ 15\\%\\ of\\ patients\\ with\\ pericardial\\ effusions\\,\\ it\\ is\\ less\\ specific\\.\\ \\ plain\\ film\\ also\\ demonstrates\\ a\\ water\\-bottle\\ configuration\\ of\\ the\\ cardiac\\ sillouette\\.\ \(0\)\
\-\ other\\ modalities\\ can\\ also\\ detect\\ pericardial\\ effusions\\.\\ \\ echocardiography\\ can\\ detect\\ effusions\\ less\\ than\\ 50cc\\ usually\\ posteriorly\\,\\ less\\ than\\ 100cc\\ anteriorly\\ and\\ posteriorly\\,\\ greater\\ than\\ 100cc\\ around\\ the\\ entire\\ ventricle\\.\\ \\ ct\\ can\\ detect\\ loculated\\ pericardial\\ effusions\\.\\ \\ mr\\ demonstrates\\ a\\ pericardial\\ stripe\\ \\>4mm\\ and\\ will\\ have\\ a\\ better\\ characterization\\ of\\ the\\ pericardial\\ fluid\\.\\ \\ \ \(0\)\
\-\ dressler\\â\\€\\™s\\ syndrome\\ consists\\ of\\ a\\ pleural\\ effusion\\ and\\ pericardial\\ effusion\\ developing\\ about\\ 2\\â\\€\\“8\\ weeks\\ after\\ acute\\ myocardial\\ infarction\\.\\ pericardial\\ effusion\\ may\\ be\\ serous\\ or\\ serosanguinous\\,\\ and\\ although\\ rare\\,\\ it\\ can\\ cause\\ cardiac\\ tamponade\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ pericardial\\:\\ 0\\.6711284102576799\ \(0\)\
\-\ effusion\\:\\ 0\\.25466513850073147\ \(0\)\
\-\ effusions\\:\\ 0\\.1783006467193324\ \(0\)\
\-\ stripe\\:\\ 0\\.1314140213257801\ \(0\)\
\-\ the\\:\\ 0\\.1292573980579617\ \(0\)\
\-\ detect\\:\\ 0\\.12328848121986166\ \(0\)\
\-\ sillouette\\:\\ 0\\.12187715252630378\ \(0\)\
\-\ dressler\\:\\ 0\\.12187715252630378\ \(0\)\
\-\ is\\:\\ 0\\.11478917118153556\ \(0\)\
\-\ 100cc\\:\\ 0\\.11261668415337266\ \(0\)\
\-\ than\\:\\ 0\\.10800388937201826\ \(0\)\
\-\ differential\\:\\ 0\\.09903575786406878\ \(0\)\
\-\ pericardium\\:\\ 0\\.0898411954335952\ \(0\)\
\-\ and\\:\\ 0\\.08661379737536055\ \(0\)\
\-\ cardiac\\:\\ 0\\.08488837950024382\ \(0\)\
\-\ chf\\:\\ 0\\.08363805774500334\ \(0\)\
\-\ of\\:\\ 0\\.08202729751738191\ \(0\)\
\-\ for\\:\\ 0\\.08084584320060255\ \(0\)\
\-\ can\\:\\ 0\\.07998569365748724\ \(0\)\
\-\ heart\\:\\ 0\\.0794856837640277\ \(0\)\
\-\ sign\\:\\ 0\\.07914213167553824\ \(0\)\
\-\ less\\:\\ 0\\.07777086859254992\ \(0\)\
\-\ density\\:\\ 0\\.0758030957044627\ \(0\)\
\-\ lucent\\:\\ 0\\.07363517439363734\ \(0\)\
\-\ seen\\:\\ 0\\.07175855616307063\ \(0\)\
\-\ anteriorly\\:\\ 0\\.06908841080465783\ \(0\)\
\-\ border\\:\\ 0\\.0674011226184454\ \(0\)\
\-\ posteriorly\\:\\ 0\\.06717657898330685\ \(0\)\
\-\ margin\\:\\ 0\\.06684668489392535\ \(0\)\
\-\ fluid\\:\\ 0\\.0660033805898805\ \(0\)\
\-\ parietal\\:\\ 0\\.06153872024636202\ \(0\)\
\-\ 200cc\\:\\ 0\\.06093857626315189\ \(0\)\
\-\ 50cc\\:\\ 0\\.06093857626315189\ \(0\)\
\-\ it\\:\\ 0\\.05851662118326106\ \(0\)\
\-\ ptca\\:\\ 0\\.058230062894512415\ \(0\)\
\-\ film\\:\\ 0\\.056949904272024114\ \(0\)\
\-\ lateral\\:\\ 0\\.056732383144330045\ \(0\)\
\-\ maximally\\:\\ 0\\.05630834207668633\ \(0\)\
\-\ 20cc\\:\\ 0\\.05630834207668633\ \(0\)\
\-\ greater\\:\\ 0\\.05614605091199745\ \(0\)\
\-\ pt\\:\\ 0\\.054846134367309195\ \(0\)\
\-\ also\\:\\ 0\\.05377084021552541\ \(0\)\
\-\ was\\:\\ 0\\.05312021531398367\ \(0\)\
\-\ demonstated\\:\\ 0\\.052570099715963985\ \(0\)\
\-\ with\\:\\ 0\\.05223037833242888\ \(0\)\
\-\ although\\:\\ 0\\.051882636561771875\ \(0\)\
\-\ space\\:\\ 0\\.050729024174718494\ \(0\)\
\-\ plain\\:\\ 0\\.05028151715845573\ \(0\)\
\-\ lasix\\:\\ 0\\.049550831903263155\ \(0\)\
\-\ fib\\:\\ 0\\.0489695945215813\ \(0\)\
\-\ mi\\:\\ 0\\.0489695945215813\ \(0\)\
\-\ characterization\\:\\ 0\\.04793986552949842\ \(0\)\
\-\ serosanguinous\\:\\ 0\\.04793986552949842\ \(0\)\
\-\ doses\\:\\ 0\\.04704787370375522\ \(0\)\
\-\ tamponade\\:\\ 0\\.04704787370375522\ \(0\)\
\-\ demonstrated\\:\\ 0\\.04683691205974595\ \(0\)\
\-\ on\\:\\ 0\\.04603374767071302\ \(0\)\
\-\ syndrome\\:\\ 0\\.04594434610854871\ \(0\)\
\-\ cardiomyopathy\\:\\ 0\\.04589991125524333\ \(0\)\
\-\ include\\:\\ 0\\.04534454320700074\ \(0\)\
\-\ visceral\\:\\ 0\\.044339360335115735\ \(0\)\
\-\ serous\\:\\ 0\\.04380467377526003\ \(0\)\
\-\ 4mm\\:\\ 0\\.04355256778430234\ \(0\)\
\-\ loculated\\:\\ 0\\.04330963134303287\ \(0\)\
\-\ evacuation\\:\\ 0\\.043075220768777796\ \(0\)\
\-\ echocardiography\\:\\ 0\\.042848757864584544\ \(0\)\
\-\ achieved\\:\\ 0\\.04262972132680261\ \(0\)\
\-\ autoimmune\\:\\ 0\\.04262972132680261\ \(0\)\
\-\ fibrillation\\:\\ 0\\.04262972132680261\ \(0\)\
\-\ coumadin\\:\\ 0\\.04241763951728966\ \(0\)\
\-\ identification\\:\\ 0\\.04221208434815812\ \(0\)\
\-\ le\\:\\ 0\\.04201266607968693\ \(0\)\
\-\ myocardial\\:\\ 0\\.04109616040662055\ \(0\)\
\-\ inr\\:\\ 0\\.04076209000206772\ \(0\)\
\-\ modalities\\:\\ 0\\.04076209000206772\ \(0\)\
\-\ chest\\:\\ 0\\.040227754538495725\ \(0\)\
\-\ without\\:\\ 0\\.04019816420126555\ \(0\)\
\-\ distant\\:\\ 0\\.03984976325681919\ \(0\)\
\-\ or\\:\\ 0\\.039768404723214044\ \(0\)\
\-\ sob\\:\\ 0\\.039436434576227274\ \(0\)\
\-\ presumed\\:\\ 0\\.03892233359783678\ \(0\)\
\-\ therapeutic\\:\\ 0\\.03856116370013829\ \(0\)\
\-\ configuration\\:\\ 0\\.038444986582312234\ \(0\)\
\-\ demonstrates\\:\\ 0\\.03828731766932819\ \(0\)\
\-\ had\\:\\ 0\\.037970864414165556\ \(0\)\
\-\ in\\:\\ 0\\.03791738938538863\ \(0\)\
\-\ consists\\:\\ 0\\.0378926046057539\ \(0\)\
\-\ induced\\:\\ 0\\.0377874053308241\ \(0\)\
\-\ pancreatitis\\:\\ 0\\.0377874053308241\ \(0\)\
\-\ 76\\:\\ 0\\.03748139690181069\ \(0\)\
\-\ sensitive\\:\\ 0\\.03748139690181069\ \(0\)\
\-\ 63\\:\\ 0\\.03681758719681867\ \(0\)\
\-\ developing\\:\\ 0\\.036465926220154994\ \(0\)\
\-\ shape\\:\\ 0\\.03613185581560216\ \(0\)\
\-\ better\\:\\ 0\\.03597088378792782\ \(0\)\
\-\ possibly\\:\\ 0\\.03581369969111709\ \(0\)\
\-\ atrial\\:\\ 0\\.03581369969111709\ \(0\)\
\-\ relief\\:\\ 0\\.03573647321367276\ \(0\)\
\-\ next\\:\\ 0\\.03558464813511893\ \(0\)\
\-\ thickness\\:\\ 0\\.035363190863156146\ \(0\)\
\-\ neoplastic\\:\\ 0\\.035219529070353625\ \(0\)\
\-\ within\\:\\ 0\\.03510019816294165\ \(0\)\
\-\ normally\\:\\ 0\\.034739732021462556\ \(0\)\
\-\ drug\\:\\ 0\\.03467391852458189\ \(0\)\
\-\ entire\\:\\ 0\\.03467391852458189\ \(0\)\
\-\ which\\:\\ 0\\.034653664633902\ \(0\)\
\-\ dissection\\:\\ 0\\.03460874712083374\ \(0\)\
\-\ metabolic\\:\\ 0\\.034544205402328915\ \(0\)\
\-\ by\\:\\ 0\\.032363390862677324\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.03227823898240154\ \(0\)\
\-\ thickened\\:\\ 0\\.03214236956831757\ \(0\)\
\-\ needed\\:\\ 0\\.03146101350469581\ \(0\)\
\-\ infectious\\:\\ 0\\.03066073958523201\ \(0\)\
\-\ increase\\:\\ 0\\.030589294883888073\ \(0\)\
\-\ cxr\\:\\ 0\\.030483540444536675\ \(0\)\
\-\ around\\:\\ 0\\.030413956316387776\ \(0\)\
\-\ increasing\\:\\ 0\\.03001101915860541\ \(0\)\
\-\ infarction\\:\\ 0\\.029913971215863356\ \(0\)\
\-\ range\\:\\ 0\\.029569725613762064\ \(0\)\
\-\ aortic\\:\\ 0\\.029448817047810702\ \(0\)\
\-\ sounds\\:\\ 0\\.029418928783636188\ \(0\)\
\-\ pa\\:\\ 0\\.029242354206159393\ \(0\)\
\-\ an\\:\\ 0\\.029142632675067552\ \(0\)\
\-\ ct\\:\\ 0\\.029014046198342077\ \(0\)\
\-\ specific\\:\\ 0\\.02887507267409226\ \(0\)\
\-\ causes\\:\\ 0\\.028793108260497118\ \(0\)\
\-\ rare\\:\\ 0\\.02876600876735147\ \(0\)\
\-\ pleural\\:\\ 0\\.028685363732764962\ \(0\)\
\-\ about\\:\\ 0\\.02852693695789299\ \(0\)\
\-\ ventricle\\:\\ 0\\.028048690216338535\ \(0\)\
\-\ view\\:\\ 0\\.027904511614445286\ \(0\)\
\-\ abnormality\\:\\ 0\\.027716990082687517\ \(0\)\
\-\ since\\:\\ 0\\.02760240724073991\ \(0\)\
\-\ dilated\\:\\ 0\\.027291652796678566\ \(0\)\
\-\ mm\\:\\ 0\\.027269999565728696\ \(0\)\
\-\ this\\:\\ 0\\.02618729421216837\ \(0\)\
\-\ enlarged\\:\\ 0\\.025976850364125482\ \(0\)\
\-\ cause\\:\\ 0\\.02595906069742251\ \(0\)\
\-\ thickening\\:\\ 0\\.025923622864183305\ \(0\)\
\-\ 15\\:\\ 0\\.02574920000709843\ \(0\)\
\-\ swelling\\:\\ 0\\.025646691357692968\ \(0\)\
\-\ along\\:\\ 0\\.02552905281740622\ \(0\)\
\-\ between\\:\\ 0\\.024758939466017194\ \(0\)\
\-\ mr\\:\\ 0\\.024655828022296444\ \(0\)\
\-\ will\\:\\ 0\\.024525552727444864\ \(0\)\
\-\ usually\\:\\ 0\\.023988661178000248\ \(0\)\
\-\ yo\\:\\ 0\\.02380599311124701\ \(0\)\
\-\ treated\\:\\ 0\\.023729210473934323\ \(0\)\
\-\ following\\:\\ 0\\.022859522561729843\ \(0\)\
\-\ weeks\\:\\ 0\\.022837218648191118\ \(0\)\
\-\ chronic\\:\\ 0\\.022618182110409182\ \(0\)\
\-\ time\\:\\ 0\\.022585937401465462\ \(0\)\
\-\ he\\:\\ 0\\.022564527075768216\ \(0\)\
\-\ presented\\:\\ 0\\.02222081833670016\ \(0\)\
\-\ been\\:\\ 0\\.02220054513176469\ \(0\)\
\-\ months\\:\\ 0\\.02218033326793638\ \(0\)\
\-\ trauma\\:\\ 0\\.022130069555247604\ \(0\)\
\-\ significant\\:\\ 0\\.022001126863293502\ \(0\)\
\-\ enhancement\\:\\ 0\\.021932713520195636\ \(0\)\
\-\ common\\:\\ 0\\.021610036387180266\ \(0\)\
\-\ patients\\:\\ 0\\.0214362821668908\ \(0\)\
\-\ prior\\:\\ 0\\.021319949412110396\ \(0\)\
\-\ anterior\\:\\ 0\\.02127574001250076\ \(0\)\
\-\ more\\:\\ 0\\.02092385307335422\ \(0\)\
\-\ physical\\:\\ 0\\.020661536537104352\ \(0\)\
\-\ acute\\:\\ 0\\.020613478661487487\ \(0\)\
\-\ most\\:\\ 0\\.01983112141785447\ \(0\)\
\-\ other\\:\\ 0\\.0197886635467487\ \(0\)\
\-\ posterior\\:\\ 0\\.019704548908810814\ \(0\)\
\-\ exam\\:\\ 0\\.019182197494821085\ \(0\)\
\-\ may\\:\\ 0\\.01917575892478145\ \(0\)\
\-\ large\\:\\ 0\\.019092617395128544\ \(0\)\
\-\ have\\:\\ 0\\.01903565812715016\ \(0\)\
\-\ but\\:\\ 0\\.018843101333353617\ \(0\)\
\-\ findings\\:\\ 0\\.01880646495688251\ \(0\)\
\-\ surgical\\:\\ 0\\.018520390231838366\ \(0\)\
\-\ after\\:\\ 0\\.01848547717728246\ \(0\)\
\-\ treatment\\:\\ 0\\.01815154832698099\ \(0\)\
\-\ male\\:\\ 0\\.016965919239225212\ \(0\)\
\-\ that\\:\\ 0\\.016536245688280497\ \(0\)\
\-\ be\\:\\ 0\\.015457773002707018\ \(0\)\
\-\ pain\\:\\ 0\\.01363545763528915\ \(0\)\
\-\ to\\:\\ 0\\.009526235457539656\ \(0\)\
